Company / Profit Margin
Whitehawk Therapeutics, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-245.1%
FY2025
5-year range
-786.4% / -23.8%
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 3 consecutive years, from -786.4% in FY2022 to -245.1% in FY2025.
Based on SEC 10-K filings.
-245.1% in FY2025 with a 3-year CAGR of +541.2%.
Improved from -432.2% to -245.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +541.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Whitehawk Therapeutics, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 9.2% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -245.1% | +9.2% |
| FY2024 | -270.0% | +37.5% |
| FY2023 | -432.2% | +45.0% |
| FY2022 | -786.4% | -3197.1% |
| FY2021 | -23.8% | - |
| FY2020 | - | - |
| FY2019 | -51.6% | +96.8% |
| FY2018 | -1605.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026